Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-01 00:31 | 2022-03-29 | SLNO | SOLENO THERAPEUTICS INC | Abingworth LLP | 10% owner | Pharmaceutical Preparations | BUY | $0.00 | 7,720,000 | $0 | 18,022,602 | +74.9% |
| 2022-02-02 01:00 | 2022-01-31 | SRRA | N/A | Abingworth LLP | 10% owner | Other | BUY | $27.00 | 150,000 | $4,050,000 | 1,314,127 | +12.9% |
| 2021-05-19 01:00 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | Abingworth LLP | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 772,727 | $8,499,997 | 2,960,231 | +35.3% |
| 2020-10-21 23:05 | 2020-10-20 | PSNL | Personalis, Inc. | Abingworth LLP | Other | Services-Medical Laboratories | SALE | $27.66 | 130,486 | $3,609,243 | 3,753,340 | -3.4% |
| 2020-10-20 23:06 | 2020-10-16 | PSNL | Personalis, Inc. | Abingworth LLP | 10% owner | Services-Medical Laboratories | SALE | $27.48 | 290,641 | $7,986,088 | 3,883,826 | -7.0% |
| 2020-10-16 23:05 | 2020-10-14 | PSNL | Personalis, Inc. | Abingworth LLP | 10% owner | Services-Medical Laboratories | SALE | $27.05 | 85,625 | $2,315,917 | 4,174,467 | -2.0% |
| 2020-10-14 23:05 | 2020-10-12 | PSNL | Personalis, Inc. | Abingworth LLP | 10% owner | Services-Medical Laboratories | SALE | $28.81 | 202,360 | $5,829,344 | 4,260,092 | -4.5% |
| 2020-08-20 23:00 | 2020-08-18 | PSNL | Personalis, Inc. | Abingworth LLP | 10% owner | Services-Medical Laboratories | SALE | $19.00 | 986,842 | $18,749,998 | 4,462,452 | -18.1% |
| 2020-07-06 23:02 | 2020-06-26 | SLNO | SOLENO THERAPEUTICS INC | Abingworth LLP | 10% owner | Pharmaceutical Preparations | BUY | $1.65 | 3,333,330 | $5,499,995 | 10,302,602 | +47.8% |
| 2019-10-29 23:01 | 2019-10-25 | SLNO | SOLENO THERAPEUTICS INC | Abingworth LLP | 10% owner | Pharmaceutical Preparations | BUY | $1.20 | 2,300,000 | $2,760,000 | 6,969,272 | +49.3% |
| 2018-05-10 00:10 | 2018-05-07 | SIEN | N/A | Abingworth LLP | Other | Other | BUY | $13.50 | 281,482 | $3,800,007 | 2,480,494 | +12.8% |
| 2014-11-01 03:43 | 2014-10-29 | SIEN | N/A | Abingworth LLP | 10% owner | Other | BUY | $15.00 | 495,000 | $7,425,000 | 2,199,012 | +29.0% |
| 2012-04-20 00:58 | 2012-04-17 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $9.62 | 4,008,341 | $38,546,211 | 1,599,168 | -71.5% |
| 2012-04-06 00:15 | 2012-04-03 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $11.00 | 2,300,000 | $25,300,000 | 5,607,509 | -29.1% |
| 2011-04-20 23:33 | 2011-04-18 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $14.87 | 4,179,174 | $62,143,482 | 7,895,826 | -34.6% |
| 2011-03-15 21:16 | 2011-03-11 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $7.50 | 2,750,000 | $20,636,000 | 12,075,000 | -18.5% |
| 2011-03-11 00:22 | 2011-03-08 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $7.50 | 550,000 | $4,125,990 | 14,825,000 | -3.6% |
| 2011-03-09 01:15 | 2011-03-04 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $7.60 | 100,000 | $760,000 | 15,375,000 | -0.6% |
| 2011-03-04 21:31 | 2011-03-02 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $7.70 | 1,200,000 | $9,239,040 | 15,475,000 | -7.2% |
| 2011-03-02 21:57 | 2011-02-28 | AMRN | AMARIN CORP PLCUK | Abingworth LLP | 10% owner | Pharmaceutical Preparations | SALE | $7.87 | 325,000 | $2,558,628 | 16,675,000 | -1.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.